JP2008508252A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008508252A5 JP2008508252A5 JP2007523166A JP2007523166A JP2008508252A5 JP 2008508252 A5 JP2008508252 A5 JP 2008508252A5 JP 2007523166 A JP2007523166 A JP 2007523166A JP 2007523166 A JP2007523166 A JP 2007523166A JP 2008508252 A5 JP2008508252 A5 JP 2008508252A5
- Authority
- JP
- Japan
- Prior art keywords
- pin
- months
- prostate cancer
- compound mixture
- total catechin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003902 lesion Effects 0.000 claims description 9
- 206010060862 Prostate cancer Diseases 0.000 claims description 6
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims 4
- 235000005487 catechin Nutrition 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims 3
- 229950001002 cianidanol Drugs 0.000 claims 3
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims 1
- 244000269722 Thea sinensis Species 0.000 claims 1
- 229960001948 caffeine Drugs 0.000 claims 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims 1
- 150000001765 catechin Chemical class 0.000 claims 1
- 229940074391 gallic acid Drugs 0.000 claims 1
- 235000004515 gallic acid Nutrition 0.000 claims 1
- 235000009569 green tea Nutrition 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 238000013188 needle biopsy Methods 0.000 description 3
- 239000002775 capsule Substances 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITBZ20040037 ITBZ20040037A1 (it) | 2004-07-27 | 2004-07-27 | Miscela di catechine ovvero polifenoli estratti dal te' verde cinese o da altri vegetali con efficacia chemiopreventiva per la prevenzione dell'insorgenza del cancro prostatico. |
| ITBZ20050004 ITBZ20050004A1 (it) | 2005-02-16 | 2005-02-16 | Miscela di catechine ovvero polifenoli estratti dal Te' Verde cinese (o da altri vegetali) Efficacia chemiopreventiva per la prevenzione dell'insorgenza del cancro prostatico e per il trattamento efficace della sintomatologia dell'ipertrofia prostati |
| PCT/IB2005/002107 WO2006013420A2 (en) | 2004-07-27 | 2005-07-21 | Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (bph) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012156634A Division JP2012236834A (ja) | 2004-07-27 | 2012-07-12 | 前立腺癌の予防および前立腺肥大（ｂｐｈ）の処置のための中国緑茶またはその他の野菜から抽出したカテキン、さらに正確にはポリフェノールの混合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008508252A JP2008508252A (ja) | 2008-03-21 |
| JP2008508252A5 true JP2008508252A5 (enExample) | 2012-09-06 |
Family
ID=35447932
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007523166A Pending JP2008508252A (ja) | 2004-07-27 | 2005-07-21 | 前立腺癌発病予防および前立腺肥大（ｂｐｈ）の総合的症状の効果的な治療のための、化学的な予防効果を有する、中国緑茶またはその他の野菜から抽出したカテキン、さらに正確にはポリフェノールの混合物 |
| JP2012156634A Pending JP2012236834A (ja) | 2004-07-27 | 2012-07-12 | 前立腺癌の予防および前立腺肥大（ｂｐｈ）の処置のための中国緑茶またはその他の野菜から抽出したカテキン、さらに正確にはポリフェノールの混合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012156634A Pending JP2012236834A (ja) | 2004-07-27 | 2012-07-12 | 前立腺癌の予防および前立腺肥大（ｂｐｈ）の処置のための中国緑茶またはその他の野菜から抽出したカテキン、さらに正確にはポリフェノールの混合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8044095B2 (enExample) |
| EP (1) | EP1781375B1 (enExample) |
| JP (2) | JP2008508252A (enExample) |
| CA (1) | CA2612149C (enExample) |
| ES (1) | ES2427170T3 (enExample) |
| PL (1) | PL1781375T3 (enExample) |
| WO (1) | WO2006013420A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2214688B1 (en) | 2007-10-26 | 2018-09-05 | Csir | Management and treatment of benign prostatic hyperplasia |
| FR2930443B1 (fr) | 2008-04-29 | 2010-06-25 | Oreal | Produit extemporane de soin a base d'un lyophilisat de microorganisme et de tensioactif(s) de hlb superieur ou egal a 12 |
| PL2348838T3 (pl) * | 2008-10-20 | 2013-10-31 | Unilever Nv | Antybakteryjna kompozycja |
| AU2010297406B2 (en) | 2009-09-24 | 2013-10-17 | Unilever Plc | Disinfecting agent comprising eugenol, terpineol and thymol |
| MX2013006435A (es) | 2010-12-07 | 2013-07-03 | Unilever Nv | Composicion para cuidado oral. |
| CN103998011B (zh) | 2011-11-03 | 2016-11-23 | 荷兰联合利华有限公司 | 个人清洁组合物 |
| IN2014MN00931A (enExample) * | 2011-11-25 | 2015-04-17 | Unilever Plc | |
| WO2013081046A1 (ja) * | 2011-11-29 | 2013-06-06 | 国立大学法人信州大学 | ブドウ梗由来抽出物 |
| CN102754832A (zh) * | 2012-07-12 | 2012-10-31 | 赵四海 | 用酚和醌融解肿瘤和改造癌细胞的治病方法 |
| JP6279591B2 (ja) * | 2012-10-15 | 2018-02-14 | ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． | 健康を促進するための緑茶抽出物と紅茶抽出物との混合物 |
| KR101492713B1 (ko) * | 2013-05-06 | 2015-02-12 | 대구한의대학교산학협력단 | 미숙 떫은 감의 분획물을 이용한 전립선 비대증 예방 또는 치료용 조성물 |
| AU2018352167B2 (en) | 2017-10-19 | 2024-03-14 | Yale University | Inhibition of androgen receptor by extracts of medicinal herbs and compositions thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5266977A (en) * | 1991-07-12 | 1993-11-30 | Linden Harry A | Lens device and method |
| US5585871A (en) * | 1995-05-26 | 1996-12-17 | Linden; Harry | Multi-function display apparatus |
| US6696484B2 (en) | 1997-10-31 | 2004-02-24 | University Of Chicago Office Of Technology And Intellectual Property | Method and compositions for regulation of 5-alpha reductase activity |
| DE19842858A1 (de) | 1998-09-18 | 2000-03-30 | Vollbrecht H Ruediger | Entkoffeinierung von Tee |
| KR100319973B1 (ko) | 1998-12-05 | 2002-04-22 | 이인수 | 녹차카테킨을 유효성분으로 하는 자궁경부 상피내종양 예방 또는 치료제 조성물 |
| AU4043900A (en) * | 1999-03-30 | 2000-10-16 | Purdue Research Foundation | Compositions containing tea catechins as cancer specific proliferation inhibitors |
| US6410052B1 (en) * | 1999-03-30 | 2002-06-25 | Purdue Research Foundation | Tea catechins in sustained release formulations as cancer specific proliferation inhibitors |
| US6431705B1 (en) * | 1999-11-10 | 2002-08-13 | Infoeye | Eyewear heart rate monitor |
| WO2002067965A1 (en) | 2001-02-22 | 2002-09-06 | Purdue Research Foundation | Compositions based on proanthocyanadin-catechin synergies for prevention and treatment of cancer |
| US6759064B2 (en) * | 2001-02-22 | 2004-07-06 | Purdue Research Foundation | Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer |
-
2005
- 2005-07-21 ES ES05768182T patent/ES2427170T3/es not_active Expired - Lifetime
- 2005-07-21 WO PCT/IB2005/002107 patent/WO2006013420A2/en not_active Ceased
- 2005-07-21 PL PL05768182T patent/PL1781375T3/pl unknown
- 2005-07-21 CA CA2612149A patent/CA2612149C/en not_active Expired - Lifetime
- 2005-07-21 EP EP05768182.7A patent/EP1781375B1/en not_active Expired - Lifetime
- 2005-07-21 JP JP2007523166A patent/JP2008508252A/ja active Pending
- 2005-07-21 US US11/658,614 patent/US8044095B2/en active Active
-
2012
- 2012-07-12 JP JP2012156634A patent/JP2012236834A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Menhinick et al. | The efficacy of pain control following nonsurgical root canal treatment using ibuprofen or a combination of ibuprofen and acetaminophen in a randomized, double‐blind, placebo‐controlled study | |
| Sardella et al. | Benzydamine hydrochloride oral rinses in management of burning mouth syndrome: a clinical trial | |
| Oleson et al. | Effect of preoperative ibuprofen on the success of the inferior alveolar nerve block in patients with irreversible pulpitis | |
| Overholt et al. | Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia | |
| Dedeoglu et al. | Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis | |
| Majid | Submucosal dexamethasone injection improves quality of life measures after third molar surgery: a comparative study | |
| Knopman | Current treatment of mild cognitive impairment and Alzheimer’s disease | |
| De Menezes et al. | Efficacy of nimesulide versus meloxicam in the control of pain, swelling and trismus following extraction of impacted lower third molar | |
| Fullmer et al. | Effect of preoperative acetaminophen/hydrocodone on the efficacy of the inferior alveolar nerve block in patients with symptomatic irreversible pulpitis: a prospective, randomized, double-blind, placebo-controlled study | |
| JP2008508252A5 (enExample) | ||
| Paiva-Oliveira et al. | Comparison of the anti-inflammatory effect of dexamethasone and ketorolac in the extractions of third molars | |
| Al-Bayaty et al. | Formulation and evaluation of a new biodegradable periodontal chip containing thymoquinone in a chitosan base for the management of chronic periodontitis | |
| Olurotimi et al. | A comparative clinical evaluation of the effect of preoperative and postoperative antimicrobial therapy on postoperative sequelae after impacted mandibular third molar extraction | |
| JP5211073B2 (ja) | 子宮内膜症の治療用の薬剤 | |
| Zeng et al. | External use of mirabilite to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis in children: a multicenter randomized controlled trial | |
| US9161936B2 (en) | Laquinimod for treatment of GABA mediated disorders | |
| Squitti et al. | Anti-copper therapies in Alzheimer's disease: new concepts | |
| Zhao et al. | A retrospective review on dysregulated autophagy in polycystic ovary syndrome: from pathogenesis to therapeutic strategies | |
| JP2024527175A (ja) | レボドパと組み合わせるオピカポンを用いたパーキンソン病に関連する疼痛の治療 | |
| Pakdaman et al. | Efficacy and safety of MLC601 in patients with mild to moderate Alzheimer disease: an extension 4-year follow-up study | |
| Sun et al. | Clinical symptoms and quality of life improvement value of ornidazole mixture in auxiliary filling treatment of patients with endodontic disease | |
| Egan et al. | HIGHER TROUGH GOLIMUMAB LEVELS ARE ASSOCIATED WITH EARLY CLINICAL AND BIOCHEMICAL RESPONSE; EARLY RESULTS OF THE GOAL-ARC STUDY | |
| Elahinia et al. | Comparative Effects of Premedication with Ibuprofen and Essential Oil of Urtica Dioica on Post-Endodontic Pain: Clinical Trial | |
| Almasi-Nasrabadi et al. | NMDA receptors interact with the retrieval memory enhancing effect of pioglitazone in mice | |
| Koch et al. | Use of metformin in polycystic ovary syndrome |